JPAC Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee

Latest Updates

This page lists all changes to TDSG-DD 203 after Release 02. This page constitutes Section 2 of Appendix 1 - Changes to donor selection guidelines.
The changes are listed with the most recent change at the bottom.

Changes introduced with Release 03
A change was made to the version control definitions and all Issue numbering information removed. No other changes where introduced.

Changes introduced with Release 04
Age See Change Notification No. 8 – 2009

Changes introduced with Release 05
Tamiflu® (oseltamivir) See Change Notification No. 28 - 2009
Relenza® (zanamivir) See Change Notification No. 29 - 2009

Changes introduced with Release 06
Acupuncture See Change Notification No. 33 - 2009
Complementary Therapy See Change Notification No. 35 - 2009

Changes introduced with Release 07
Body Piercing See Change Notification No. 02 - 2010
Inoculation Injury See Change Notification No. 04 - 2010

Changes introduced with Release 08
West Nile Virus (WNV) See Change Notification No. 09 - 2010

Changes introduced with Release 09
Immunization - Live See Change Notification No. 06 - 2011
BCG See Change Notification No. 07 - 2011
Infertility See Change Notification No. 08 - 2011
Sexually Transmitted Disease See Change Notification No. 09 - 2011

Changes introduced with Release 10
West Nile Virus See Change Notification No. 11 - 2011

Changes introduced with Release 11
Porphyria See Change Notification No. 20 - 2011
Immunosuppression See Change Notification No. 21 - 2011

Changes introduced with Release 12
XMRV See Change Notification No. 25 - 2011
Hepatitis C See Change Notification No. 27 - 2011

Changes introduced with Release 13
West Nile Virus (WNV) See Change Notification No. 05 - 2012

Changes introduced with Release 14
Acne See Change Notification No. 15 - 2012
Pregnancy See Change Notification No. 16 - 2012
Psoriasis See Change Notification No. 17 - 2012
Toxoplasmosis See Change Notification No. 18 - 2012

Changes introduced with Release 15
West Nile Virus (WNV) See Change Notification No. 01 - 2013

Changes introduced with Release 16
Hepatitis B See Change Notification No. 08 - 2013
Hepatitis B Post Immunization See Change Notification No. 09 - 2013
Infection - Chronic See Change Notification No. 10 - 2013

Changes introduced with Release 17
Acupuncture See Change Notification No. 02 - 2014
Alitretinoin, Toctino, Acne and Dermatitis See Change Notification No. 03 - 2014
Central Nervous System Disease See Change Notification No. 05 - 2014
Hepatitis of Unknown Origin See Change Notification No. 08 - 2014
Kidney Disease See Change Notification No. 10 - 2014
Malignancy See Change Notification No. 11 - 2014
Mental Health Problems See Change Notification No. 12 - 2014
Sarcoidosis See Change Notification No. 13 - 2014
South American Trypanosomiasis Risk See Change Notification No. 14 - 2014
Paratyphoid and Typhoid See Change Notification No. 15 - 2014

Changes introduced with Release 18
Haematological Disease See Change Notification No. 30 - 2014
SARS See Change Notification No. 31 - 2014
Tissues Safety See Change Notification No. 32 - 2014
Homosexual & Bisexual Individuals See Change Notification No. 36 - 2014
Sex Change See Change Notification No. 39 - 2014

Changes introducted with Release 19
Viral Haemorrhagic Fever Risk   See Change Notification No. 43 – 2014

Changes Introduced with Release 20
Communication Difficulties See Change Notification No.7 - 2015
Complementary Therapy See Change Noficiation No.8 - 2015
Infertility See Change Notification No.9 -  2015

Changes Introduced with Release 21
Complementary Therapy See Change Notification No. 12 - 2015
Injectable Tanning Agents See Change Notification No.15 - 2015

Changes Introduced with Release 22
Age pulmonary patch allografts See Change Notification No.16 -2015

Changes Introduced with Release 23
Appendix 2 Table of Immunizations   See Change Notification No. 04 - 2016
Tropical Viruses                                 See Change Notification No. 08 - 2016
West Nile Virus                                  See Change Notification No. 09 - 2016
Viral Haemorrhagic Fever                  See Change Notification No. 11 -2016

Changes Introduced with Release 24

Tropical Viruses                                   See Change Notification No. 014 - 2016
Viral Haemorrhagic Fever  
                    See Change Notification No. 015 - 2016

Changes Introduced with Release 25

Endoscopy                                                          See Change Notificaiton No. 24 - 2016
Fibromyalgia                                                       See Change Notificiation No. 25 - 2016
Necrotising Fasciitis                                            See Change Notification No. 26 - 2016

Osteogenesis Imperfecta                                    See Change Notificiaton No. 27 - 2016    
Severe Excercise Intolerance Disease (SEID)     See Change Notification No. 28 - 2016
Xenotransplantation                                            See Change Notification No. 29 - 2016  

Changes Introduced with Release 26

Cardiomyopathy                See Change Notification No. 44 - 2016
Ehlers Danlos Syndrome  See Change Notification No. 45 - 2016 

Hepatitis A                         See Change Notification No. 46 - 2016
Marfans Syndrome            See Change Notification No. 47 - 2016
Transfusion                        See Change Notification No.48 - 2016 

Changes Introduced with Release 27

Malignancy       See Change Notifcation No. 05 - 2017

Changes Introduced with Release 28

Malaria See Change Notification No. 17 - 2017